gr
In October of 2011 LEAP delivered a custom e-Detailing solution in UCB Greece. UCB Greece is the first Greek company to implement an e-Detailing solution based on tablets (iPad 2), in the Greek phaurmaceutical market. LEAP’s vertical solution in e-Detailing, gives the detailers an easy to use medium to deliver engaging and more successful presentations. By implementing our solution UCB Greece, managed to reduced costs at all levels and increase the effectiveness of product communication.
UCB is a leading company in global pharmaceutical, that places the patient at the center of all its activities. UCB’s mission is to improve the quality of life of patients suffering from severe immunological and central nervous system disorders as well as respiratory system and allergy illnesses. This is achieved through the discovery, development and marketing of innovative products. While aspiring towards offering innovative new medicines, UCB continues to expand its therapeutic areas of interest to satisfy unmet medical needs.
UCB envisions becoming a leading biopharmaceutical company of the next generation via a comparatively higher ratio of investment in research and development per employee than any other company in all fields of business within Europe coupled with its commitment to strategic acquisitions and partnering.
